medCPU, Inc., a NYC-based provider of enterprise clinical decision support solutions, closed an $8m financing round.
This consist of $5m series B-2 equity and $3m in debt financing. The equity round was led by Merck Global Health Innovation Fund and New Richmond Ventures, and debt financing was provided by Silicon Valley Bank.
This additional funding will enable medCPU to continue to grow in the dynamic clinical decision support marketplace.
Led by Sonia Ben-Yehuda, President and Co-Founder, medCPU delivers real-time enterprise decision support software and services through proprietary Advisor technology that captures the complete clinical picture from clinicians’ free-text notes, dictations, discharge summaries and structured documentation entered into any Electronic Medical Record (EMR), and analyzes it against a library of best-practice content, generating real-time prompts for care consideration.